(Q36896096)

16 August 2017

Graves' disease: immunological and immunogenetic indicators of relapse (English)

1 reference

16 August 2017

1 reference

de Bruin TW

1

1 reference

16 August 2017

Bolk JH

2

1 reference

16 August 2017

Bussemaker JK

3

1 reference

16 August 2017

Stijnen T

4

1 reference

16 August 2017

Schreuder GM

5

1 reference

16 August 2017

de Vries RR

6

1 reference

16 August 2017

van der Heide D

7

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 1988

1 reference

16 August 2017

1 reference

16 August 2017

296

1 reference

16 August 2017

6632

1 reference

16 August 2017

1292-1295

1 reference

The estimation and significance of the logarithm of a ratio of frequencies

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

The human major histocompatibility complex and endocrine disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Thyroid-Stimulating Autoantibodies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Immune mechanisms in Graves' disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Protection from autoimmune disease as the third function of the major histocompatibility gene complex

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Thyrotropin Displacement Activity of Serum Immunoglobulins from Patients with Graves’ Disease*

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

HLA antigens in Graves' disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Goitre size and outcome of medical treatment of Graves' disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Prediction of outcome in Graves' disease after carbimazole treatment.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2545766

Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy

27 June 2018

1 reference

12 December 2020

Prediction of relapse in hyperthyroid Graves' disease

1 reference

12 December 2020

Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease

1 reference

12 December 2020

HLA and Graves' disease: an association with HLA-DRw3

1 reference

12 December 2020

HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course

1 reference

12 December 2020

Gardnerella vaginalis: pathogen or commensal?

1 reference

12 December 2020

A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype

1 reference

12 December 2020

Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis

1 reference

12 December 2020

Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease

1 reference

12 December 2020

The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease

1 reference

12 December 2020

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test

1 reference

12 December 2020

Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association

1 reference

12 December 2020

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

1 reference

12 December 2020

Identifiers

1 reference

16 August 2017

PubMed publication ID

3133054

1 reference